BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 26248734)

  • 1. MAGI3 Suppresses Glioma Cell Proliferation via Upregulation of PTEN Expression.
    Ma Q; Zhang Y; Meng R; Xie KM; Xiong Y; Lin S; He ZL; Tao T; Yang Y; Zhao JZ; He JQ
    Biomed Environ Sci; 2015 Jul; 28(7):502-9. PubMed ID: 26248734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.
    Ma Q; Yang Y; Feng D; Zheng S; Meng R; Fa P; Zhao C; Liu H; Song R; Tao T; Yang L; Dai J; Wang S; Jiang WG; He J
    Oncotarget; 2015 Nov; 6(34):35851-65. PubMed ID: 26452219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway.
    Liu C; Wu H; Li Y; Shen L; Yu R; Yin H; Sun T; Sun C; Zhou Y; Du Z
    J Neurooncol; 2017 Nov; 135(2):263-272. PubMed ID: 28887597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma.
    Tu M; Cai L; Zheng W; Su Z; Chen Y; Qi S
    Mol Med Rep; 2017 Apr; 15(4):1713-1721. PubMed ID: 28259931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway.
    Nan Y; Guo L; Song Y; Wang L; Yu K; Huang Q; Zhong Y
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1477-1487. PubMed ID: 28401302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-130b can suppress proliferation of glioma cells through targeting PTEN to regulate AKT pathway.
    Niu H; Liu Y; Wang Y; Tian Y; Jiang H; Cao S; Yang M; Li S
    J BUON; 2020; 25(4):2059-2065. PubMed ID: 33099953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway.
    Chai C; Song LJ; Han SY; Li XQ; Li M
    CNS Neurosci Ther; 2018 May; 24(5):369-380. PubMed ID: 29316313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway.
    Dasari VR; Kaur K; Velpula KK; Gujrati M; Fassett D; Klopfenstein JD; Dinh DH; Rao JS
    PLoS One; 2010 Apr; 5(4):e10350. PubMed ID: 20436671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX; Zhang ZP; Zhao J; Liu JP
    Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN reconstitution alters glioma responses to c-Met pathway inhibition.
    Goodwin CR; Lal B; Ho S; Woodard CL; Zhou X; Taeger A; Xia S; Laterra J
    Anticancer Drugs; 2011 Oct; 22(9):905-12. PubMed ID: 21654317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
    Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma.
    Bao L; Li X
    Mol Cell Biochem; 2019 Oct; 460(1-2):67-79. PubMed ID: 31218569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway.
    Gu Y; Cai R; Zhang C; Xue Y; Pan Y; Wang J; Zhang Z
    FASEB J; 2019 Jan; 33(1):441-454. PubMed ID: 30024792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of microRNA-130b inhibits glioma cell proliferation and invasion, and induces apoptosis by PTEN/AKT signaling.
    Gu JJ; Fan KC; Zhang JH; Chen HJ; Wang SS
    Int J Mol Med; 2018 Jan; 41(1):284-292. PubMed ID: 29115407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.
    Jiang L; Wang C; Lei F; Zhang L; Zhang X; Liu A; Wu G; Zhu J; Song L
    Oncotarget; 2015 Apr; 6(10):8286-99. PubMed ID: 25823655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Park CM; Park MJ; Kwak HJ; Lee HC; Kim MS; Lee SH; Park IC; Rhee CH; Hong SI
    Cancer Res; 2006 Sep; 66(17):8511-9. PubMed ID: 16951163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C; Zhang B; Li YL; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.